World of DTC Marketing

JULY 21, 2021

They research the drug online and ask their physician about it if they decide it’s a treatment option. 3hree: DTC marketing minimizes the side effects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.” This is perhaps the biggest misunderstanding.

Marketing 285

Marketing Prescription Side effects Doctors 285

World of DTC Marketing

MARCH 23, 2022

Accelerated Approval allows for early access to drugs and biologics based on initial evidence of safety and effectiveness, while confirmatory studies required to verify clinical benefits are ongoing. The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012. Do patients care? Do patients care?

Patients 200

Patients FDA Doctors Physicians 200

MedCity News

OCTOBER 16, 2023

King said: And so not having that in a single area, single curated type of place makes it very difficult to really gain insights out of that data and to be able to have actionable things for a provider or a physician or a hospital operator to make decisions on how we can improve and better patient care. October 8 was when I saw it in action.

Healthcare 313

Healthcare Healthcare Patients Doctors 313

World of DTC Marketing

OCTOBER 20, 2020

J&J’s refusal to release any information regarding a COVID-19 vaccination trial that J&J paused earlier this month comes on the heels of a recent and widely-touted joint pledge of prudence and caution on vaccine trial safety by nine drug companies, including J&J, working on COVID 19 vaccines.

Pharma 214

Pharma Government Physicians Safety 214

World of DTC Marketing

MAY 25, 2022

Healthcare across the country needs to build on proven hospital-based violence intervention (HVIP) models to create coordinated, systemwide programs that give doctors, nurses, physician assistants, and social workers the tools they need to talk with the people they treat about preventing gun injuries.

Doctors 46

Doctors Healthcare Healthcare Physicians 46

MedCepts

NOVEMBER 7, 2017

This article deals on the psychology of selling to physicians. In the medical trade, it is normal for the physician to interact with numerous medical representatives. Normally, a physician would choose and deal with a few reps on a regular basis. The Exceptional Sales Representative and Physician Relationship.

Physicians 52

Physicians Sales Doctors Medical 52

PM360

NOVEMBER 27, 2023

Up to now, drug safety teams have relied primarily on reactive reporting systems for pharmacovigilance (PV) or real-world drug safety monitoring. Physicians must form hypotheses about the AE’s cause and seek information to prove or discredit the hypothesis. Yet, correlation does not signify causation.

Safety 106

Safety Electronics Patients Physicians 106

Healthcare Success

JULY 5, 2022

Marketing to doctors, physicians, surgeons, and other health care professionals can be extremely challenging, complicated, and expensive. Today's traditional and digital marketing technologies offer unprecedented opportunities to reach physicians and other health care professionals cost-effectively—and at scale.

Doctors 59

Doctors Physicians Marketing Prospecting 59

Pharmaceutical Technology

APRIL 11, 2023

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies.

Safety 59

Safety Food and Drug Administration FDA Side effects 59

World of DTC Marketing

DECEMBER 23, 2020

How do physicians feel about patients asking for a new drug via a telehealth visit, and can the prescriber evaluate whether a patient is a good candidate or a new drug? They’re going to go online where they can read the safety warnings that too often than not scare them because they lack context. Is TV the best channel?

Prescription 249

Prescription Doctors Side effects Marketing 249

PM360

AUGUST 24, 2023

biosimilars market is evolving rapidly and pharma marketing programs need to evolve as well to better meet physician needs. As we found in our latest physician survey, physicians are actively seeking more information on key topics such as patient affordability, patient eligibility, clinical results, formulary coverage, and more.

Marketing 97

Marketing Physicians Electronics Patients 97

Nixon Gwilt Law

JULY 23, 2024

In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services.

Physicians 52

Physicians FDA Safety Management 52

World of DTC Marketing

MARCH 16, 2021

Do I have a responsibility to share — on every occasion, random and formal, to family, friends, and strangers alike — my knowledge on the vaccines, monoclonal antibodies, the latest news from the Lancet or JAMA, why RNA is not voodoo, how Phase 4 safety trials are happening as I write…The answer is simple: yes.

Marketing 180

Marketing Pharma Specialization Doctors 180

European Pharmaceutical Review

SEPTEMBER 22, 2022

EBT-101, a CRISPR-Cas9 gene editing system delivered by adenovirus-associated virus vector serotype 9 (AAV9) has been administered to the first individual in a Phase I/II trial designed to establish its safety and efficacy. Biodistribution, pharmacodynamic, and efficacy assessments will also be conducted. “It

Patients 145

Patients Safety Medicine Physicians 145

European Pharmaceutical Review

OCTOBER 25, 2022

The safety profiles for both Imjudo added to Imfinzi and for Imfinzi on its own were consistent with previous data for the medications. No new safety precautions were identified. Liver cancer is the sixth most common cancer worldwide with 36,000 people diagnosed in the US every year.

Food and Drug Administration 111

Food and Drug Administration Patients Safety Physicians 111

Nixon Gwilt Law

JULY 23, 2024

In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services.

Physicians 52

Physicians FDA Safety Management 52

Celeritas

SEPTEMBER 26, 2022

Many hospitals want to support their physicians in expanding their expertise by providing useful educational resources. Safety and Security: Geriatricians and Pediatricians mainly manage patients who are either too old or too young to take care of themselves. Now hospitals and elderly homes can ensure the safety of their charges.

Physicians 52

Physicians Patients Medical Management 52

European Pharmaceutical Review

NOVEMBER 7, 2023

The new Phase II data, in addition to existing studies, add to evidence that domvanalimab has a differentiated safety and tolerability profile relative to published data from studies with Fc-enabled anti-TIGIT antibodies.

Safety 114

Safety Patients Physicians Medical 114

Pharmaceutical Technology

SEPTEMBER 5, 2022

Simpson alleged in a lawsuit filed in the District of New Jersey that Bayer paid kickbacks to physicians and hospitals to prompt them to use Trasylol and Avelox. Additionally, the company was accused of downplaying Trasylol’s safety risks. Later on, the company withdrew Trasylol and Baycol from the market for safety reasons.

Safety 105

Safety Government Physicians Healthcare 105

Nixon Gwilt Law

AUGUST 2, 2022

CMS will delay the requirement for an in-person visit with the physician/practitioner (and FQHCs/RHCs) within 6 months prior to an initial mental health telehealth service, and again at subsequent intervals for purposes of diagnosis/evaluation/treatment of a mental health disorder.

Physicians 52

Physicians Training Education Patients 52

European Pharmaceutical Review

MARCH 18, 2024

Gardner Family Center for Parkinson’s Disease Research Endowed Chair in UC’s Department of Neurology and Rehabilitation Medicine and a physician at the UC Gardner Neuroscience Institute explained. and Joan A. He noted that this means the treatment dose needs to be increased or administered more often.

Food and Drug Administration 98

Food and Drug Administration Medicine Physicians Food 98

European Pharmaceutical Review

SEPTEMBER 15, 2022

The long-term data analyses of the Phase III KEEPsAKE 1 and 2 trials also revealed no new observed safety signals through 100 weeks. ” Skyrizi was generally well-tolerated and no new safety signals were noted in both KEEPsAKE 1 and 2 at 100 weeks of treatment. . Serious treatment-emergent adverse events (TEAEs) occurred at 7.6

Safety 94

Safety Physicians Patients Consulting 94

Pharmaceutical Technology

FEBRUARY 20, 2023

Syfovre has been approved for use in people with GA with or without subfoveal involvement and offers dosing flexibility with a regimen of every 25 to 60 days for patients and physicians. Syfovre’s safety profile is well-demonstrated after approximately 12,000 injections over 24 months.

Food and Drug Administration 98

Food and Drug Administration FDA Physicians Food 98

European Pharmaceutical Review

OCTOBER 19, 2023

The results presented at EACS complement the results observed in multiple Phase III clinical trials, which demonstrate the sustained efficacy, safety profile, and high barrier to resistance of Biktarvy,” stated Dr Fernando Bognar, Vice President of Global Medical Affairs for HIV at Gilead Sciences.

Safety 104

Safety Physicians Food Medical 104

European Pharmaceutical Review

SEPTEMBER 8, 2022

Comparing the use of common antiretroviral therapy (ART) regimens in pregnancy suggests that dolutegravir-based regimens have a higher probability of human immunodeficiency virus type 1 (HIV-1) viral suppression at delivery.

Medicine 105

Medicine Safety Physicians Pharmaceutical 105

European Pharmaceutical Review

FEBRUARY 6, 2023

Other efficacy measures showed significantly improvement: skin thickness (defined by the modified Rodnan Skin Score, mRSS), lung function (percentFVC), physician-reported assessment and quality of life evaluations. The study safety profile of the oral therapy demonstrated that FT011 was safe and well tolerated.

Physicians 98

Physicians Patients Safety Pharmaceutical 98

Referral MD

DECEMBER 9, 2024

While a physician may determine a treatment plan, they must get the insurers green light to ensure coverage. Patient Safety Prior authorization protects patients by: Verifying that prescribed medications or treatments are safe. Level 3: External review by an impartial physician. Why Does Prior Authorization Exist?

Healthcare 69

Healthcare Healthcare Insurance Healthcare Provider 69

European Pharmaceutical Review

AUGUST 17, 2023

“We are pleased to join this collaborative effort to develop and assess the safety, immunogenicity, and effectiveness of an adenovirus type 4-based vaccine expressing the SARS-CoV-2 spike protein as a novel approach to the prevention of COVID-19,” commented Dr Peter Wright, infectious disease, and international health physician at Dartmouth Health’s (..)

Manufacturing 98

Manufacturing Medicine Physicians Safety 98

MaBiCo

JUNE 7, 2023

Whether you are in the pharmaceuticals, dermoceuticals, OTC, medical devices, or whatever business relates with patients and their health, you need to have a clearly defined strategy on how to approach physicians. Selling to private practice doctors is different than selling to healthcare organizations.

Sales Strategy 98

Sales Strategy Medical sales Doctors Sales 98

pharmaphorum

DECEMBER 9, 2022

There was also encouraging safety data observed within a wider group of 92 patients: 3% of patients experienced Grade 3 or higher cytokine release syndrome (CRS) and 8% experienced Grade 3 or higher immune effector cell-associated neurotoxicity syndrome (ICANS). Obe-cel showed comparable expansion and initial persistence (median follow-up 6.4

Food and Drug Administration 98

Food and Drug Administration Safety Biopharma Patients 98

European Pharmaceutical Review

DECEMBER 6, 2023

Therefore, with data showing that iptacopan is an “efficacious oral treatment with a demonstrated safety profile [this] could be practice-changing for physicians and help relieve burdens experienced by people with PNH,” Dr Pullarkat added. Patients avoiding transfusion: The transfusion avoidance rate was 95.2 percent for anti-C5.

Food and Drug Administration 108

Food and Drug Administration Patients Physicians Food 108

European Pharmaceutical Review

APRIL 10, 2024

Over the past decade, there has been an increase in discussions involving industry stakeholders, regulatory agencies, and physicians about developments in the emerging microbiome therapeutics industry. During the development of clinical trials that use faecal-derived material, the necessity of safety is paramount.

Safety 95

Safety Patients Medical FDA 95

Pharmaceutical Technology

DECEMBER 7, 2022

GlobalData anticipates that this safety update will likely raise physician and regulator vigilance regarding long-term Dupixent use but is unlikely to impact overall prescribing patterns for the product. This will, however, likely trigger Dupixent’s competitors to look more closely at the safety of their products.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

Pharma Marketing Network

MAY 12, 2021

Physicians and patients raise legitimate questions and concerns about the safety, effectiveness, and accessibility of telehealth. Wearable technology allows physicians to check in on the health of their patients in between physical office visits. Still though, there are obstacles around a vast adoption of telehealth services.

Physicians 59

Physicians Patients Safety Marketing 59

PM360

SEPTEMBER 15, 2022

In another unique partnership, the American College of Chest Physicians (CHEST) is teaming up with the nonprofit Three Lakes Foundation on an initiative called “Bridging Specialties: Timely Diagnosis for ILD Patients.” But ultimately, you need multiple modes of education across several formats to have the most impact.”.

Education 105

Education Physicians Patients Pharma 105

Evolve Your Success

DECEMBER 5, 2023

She shines a light on the competitiveness of the market, the preferences of physicians, and even personal growth. However, what that would look like is the physician says, “We need this.” The physician says, “Is X company around?” For the most part, they understand but these physicians can be very particular.

Medical sales 147

Medical sales Sales Physicians Medical 147

Pharmaceutical Technology

APRIL 4, 2023

The CLIMB-111 and CLIMB-121 trials are designed to evaluate the efficacy and safety of a single exa-cel dose in TDT or SCD patients aged 12 to 35 years. The BLAs are supported by data obtained from the ongoing Phase III CLIMB-111 and CLIMB-121 trials, along with an ongoing long-term follow-up CLIMB-131 trial.

Food and Drug Administration 98

Food and Drug Administration FDA Medicine Pharmaceutical 98